AZ PFKFB3 26

CAS No. 1704740-52-2

AZ PFKFB3 26( —— )

Catalog No. M26619 CAS No. 1704740-52-2

AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
2MG 29 In Stock
5MG 41 In Stock
10MG 72 In Stock
25MG 164 In Stock
50MG 277 In Stock
100MG 386 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AZ PFKFB3 26
  • Note
    Research use only, not for human use.
  • Brief Description
    AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM.
  • Description
    AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM. The IC50s for PFKFB1 and PFKFB2 are 2.06 and 0.384 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1704740-52-2
  • Formula Weight
    402.498
  • Molecular Formula
    C24H26N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (12.42 mM)
  • SMILES
    CC(C)Cn1cc(C#N)c2cc(Oc3ccc(NC(=O)[C@@H]4CCCN4)cc3)ccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biratsi A, et al. A highly conserved mechanism for the detoxification and assimilation of the toxic phytoproduct L-azetidine-2-carboxylic acid in Aspergillus nidulans. Sci Rep. 2021 Apr 1;11(1):7391.
molnova catalog
related products
  • Dexamethasone palmit...

    Dexamethasone palmitate, a lipophilic prodrug of Dexamethasone, shows a 47-fold lower affinity for the glucocorticoid receptor than Dexamethasone.

  • ML198

    ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase.

  • AMG-1694

    AMG-1694, a potent disruptor of the glucokinase–glucokinase regulatory protein (GK-GKRP) complex, operates by promoting the dissociation of this complex, thereby indirectly enhancing GK enzymatic activity with an IC50 of 7 nM.